Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Eleni Karatza, Sophia L. Markantonis, Andria Savvidou, Anastasia Verentzioti, Anna Siatouni, Athanasia Alexoudi, Stylianos Gatzonis, Evgenia Mavrokefalou & Vangelis Karalis. (2020) Pharmacokinetic and pharmacodynamic modeling of levetiracetam: investigation of factors affecting the clinical outcome. Xenobiotica 50:9, pages 1090-1100.
Read now
Read now
Johan Zelano & Elinor Ben-Menachem. (2016) Treating epileptic emergencies – pharmacological advances. Expert Opinion on Pharmacotherapy 17:16, pages 2227-2234.
Read now
Read now
Wei Jiang, Xuefeng Wang & Shengnian Zhou. (2016) Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis. Expert Opinion on Drug Safety 15:3, pages 357-365.
Read now
Read now
Gashirai K. Mbizvo, Pete Dixon, Jane L. Hutton & Anthony G. Marson. (2014) The adverse effects profile of levetiracetam in epilepsy: a more detailed look. International Journal of Neuroscience 124:9, pages 627-634.
Read now
Read now
Catherine Maurice & Warren P Mason. (2014) Seizure management in patients with gliomas. Expert Review of Neurotherapeutics 14:4, pages 367-377.
Read now
Read now
Articles from other publishers (84)
Rinky Agarwal, Deependra Jhankal, Rajesh Yadav & K. K. Jhankal. (2023) Development of MoS2 flower-adorned pencil graphite electrode for electro-kinetic investigations and voltammetric quantification of anti-epileptic drug levetiracetam. Journal of Applied Electrochemistry.
Crossref
Crossref
Ernestina Hernández García, Lizbeth Naranjo, Luz Adriana Pichardo-Macías, María Josefa Bernad Bernad, Lucila Isabel Castro-Pastrana, Matilde Ruíz García, Tanya Alejandra García Bernal, Jessica Lizbeth Mendoza Solís, David Calderón Guzmán, Luisa Díaz-García, Julieta Griselda Mendoza-Torreblanca & Juan Luis Chávez Pacheco. (2023) Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study. Children 10:11, pages 1775.
Crossref
Crossref
Jamir Pitton Rissardo, Nilofar Vora, Bejoi Mathew, Vikas Kashyap, Sara Muhammad & Ana Letícia Fornari Caprara. (2023) Overview of Movement Disorders Secondary to Drugs. Clinics and Practice 13:4, pages 959-976.
Crossref
Crossref
Xiangqi Meng, Yan Liu, Lin Yang, Rui Li, Hualei Wang, Yaling Shen & Dongzhi Wei. (2023)
Rational identification of a high catalytic efficiency leucine dehydrogenase and process development for efficient synthesis of
l
‐phenylglycine
. Biotechnology Journal 18:5.
Crossref
Crossref
Iván Ignacio-Mejía, Itzel Jatziri Contreras-García, Julieta Griselda Mendoza-Torreblanca, Omar Noel Medina-Campos, José Pedraza-Chaverri, Mercedes Edna García-Cruz, Antonio Romo-Mancillas, Saúl Gómez-Manzo, Cindy Bandala, María Elena Sánchez-Mendoza, Luz Adriana Pichardo-Macías & Noemí Cárdenas-Rodríguez. (2023) Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model. Biomedicines 11:3, pages 848.
Crossref
Crossref
Nishat Afza, Shaheen Fatma, Faraz Ghous, Soni Shukla, Sonam Rai, Krishna Srivastava & Abha Bishnoi. (2023) An efficient multicomponent synthesis, characterization, SAR, In-silico ADME prediction and molecular docking studies of 2-Amino-7-(substituted-phenyl)-3-cyano-4-phenyl-4,5,6,7-tetrahydropyrano[2,3-b] pyrrole-5-carboxylic acid derivatives and their in-vitro antimicrobial activity. Journal of Molecular Structure 1276, pages 134721.
Crossref
Crossref
Atef M. Abdel Hamid, Asmaa H. Amer, Mohamed G. Assy, Wael A. Zordok, Samar M. Mouneir, Samar El-Kalyoubi & Wesam S. Shehab. (2023) Synthesis, pharmacological evaluation, DFT calculation, and theoretical investigation of spirocyclohexane derivatives. Bioorganic Chemistry 131, pages 106280.
Crossref
Crossref
Arvinpreet Kour & Ajaydeep Singh. (2023) Levetiracetam-induced drug reaction: violaceous discrete maculopapular rash: A case report. Apollo Medicine 20:1, pages 83.
Crossref
Crossref
Aeyaz Ahmad Bhat, Iqubal Singh, Nitin Tandon & Runjhun Tandon. (2023) Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review). European Journal of Medicinal Chemistry 246, pages 114954.
Crossref
Crossref
Gabriel Servilha-Menezes, Alan Talevi & Norberto Garcia-Cairasco. 2023. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
39
62
.
Vasileios Papaliagkas, Konstantinos Notas, Evangelia Chatzikyriakou, Maria Moschou, Sevasti Bostanjopoulou, Georgios Hadjigeorgiou & Vasilios K. Kimiskidis. (2022) Brivaracetam for dyskinetic cerebral palsy. Epileptic Disorders 24:3, pages 614-616.
Crossref
Crossref
Fucheng Leng, Koen Robeyns, Tom Leyssens & Oleksii Shemchuk. (2022) Combining Racetams with a Sweetener through Complexation. Crystal Growth & Design 22:5, pages 3016-3023.
Crossref
Crossref
Maja Hochbaum, Ricardo Kienitz, Felix Rosenow, Juliane Schulz, Lena Habermehl, Lisa Langenbruch, Stjepana Kovac, Susanne Knake, Felix von Podewils, Sophie von Brauchitsch, Mario Hamacher, Adam Strzelczyk & Laurent M. Willems. (2022) Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020. Epilepsy & Behavior 130, pages 108666.
Crossref
Crossref
Itzel Jatziri Contreras-García, Noemí Cárdenas-Rodríguez, Antonio Romo-Mancillas, Cindy Bandala, Sergio R. Zamudio, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, Julieta Griselda Mendoza-Torreblanca & Luz Adriana Pichardo-Macías. (2022) Levetiracetam Mechanisms of Action: From Molecules to Systems. Pharmaceuticals 15:4, pages 475.
Crossref
Crossref
Jannapas Tharavichitkun, Tinonkorn Yadee, Poomchai Angkaow & Thanarat Suansanae. (2022) Evaluating Therapeutic Equivalence of Generic and Original Levetiracetam in Patients with Epilepsy: A Retrospective Study. Neurology International 14:1, pages 271-283.
Crossref
Crossref
R. K. BarooahDrDrAnkur AnandDrDr. (2022) LEVETIRACETAM INDUCED CUTANEOUS RED RASHES: AN EXTREMELY RARE ADVERSE DRUG REACTION. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 7-8.
Crossref
Crossref
Ryan J. McGinn, Majid S. Aljoghaiman & Sunjay V. Sharma. (2022) Levetiracetam vs phenytoin prophylaxis in severe traumatic brain injury: Systematic review and meta-analysis. Interdisciplinary Neurosurgery 27, pages 101394.
Crossref
Crossref
Bohdan A. Chalyk, Andrii V. Khutorianskyi, Bohdan V. Vashchenko, Kyrylo Danyleiko, Anastasiia Grynyova, Anastasiia O. Osipova, Andriy Kozytskiy, Darya Syniuchenko, Anton Tsymbaliuk, Konstantin S. Gavrilenko, Angelina V. Biitseva, Dmitriy M. Volochnyuk, Igor V. Komarov & Oleksandr O. Grygorenko. (2021)
Reductive Recyclization of sp
3
-Enriched Functionalized Isoxazolines into α-Hydroxy Lactams
. The Journal of Organic Chemistry 87:2, pages 1001-1018.
Crossref
Crossref
Priyajyoti Chakma, Dr. Bappaditya Roy & Dr. Punyadhar Das. (2021) Levetiracetum Induced Angioedema without Prior Reaction to Phenytoin. Eastern Journal of Psychiatry 19:1, pages 33-35.
Crossref
Crossref
Marie‐Gabrielle Goossens, Paul Boon, Wytse Wadman, Chris Van den Haute, Veerle Baekelandt, Alain G. Verstraete, Kristl Vonck, Lars E. Larsen, Mathieu Sprengers, Evelien Carrette, Jana Desloovere, Alfred Meurs, Jean Delbeke, Christian Vanhove & Robrecht Raedt. (2021) Long‐term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy. Epilepsia 62:3, pages 659-670.
Crossref
Crossref
Gashirai K Mbizvo, Bharath Chandrasekar, Sarah J Nevitt, Pete Dixon, Jane L Hutton & Anthony G Marson. (2020) Levetiracetam add-on for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2020:6.
Crossref
Crossref
Bhuvanachandra Pasupuleti, Vamshikrishna Gone, Ravali Baddam, Raj Kumar Venisetty & Om Prakash Prasad. (2020) Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study. Current Drug Metabolism 21:2, pages 126-131.
Crossref
Crossref
Satoru Takahashi, Kazuhide Shimizu, Motoki Inaji, Satoka Hashimoto, Shinji Yamamoto & Taketoshi Maehara. (2019) Effectiveness of perampanel as a first add-on antiepileptic drug for the treatment of partial epilepsy. Epilepsy & Behavior 100, pages 106492.
Crossref
Crossref
Tomohiro Kawaguchi & Teiji Tominaga. (2022) A rare case of drug-induced liver injury caused by levetiracetam. Asian Journal of Neurosurgery 14:03, pages 878-882.
Crossref
Crossref
Toshiki Inaba, Nobukazu Miyamoto, Kenichiro Hira, Yuji Ueno, Kazuo Yamashiro, Masao Watanabe, Yoshiaki Shimada, Nobutaka Hattori & Takao Urabe. (2019) Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion. Neuroscience 414, pages 255-264.
Crossref
Crossref
Ting Wu, Katsutoshi Ido, Makoto Ohgoh & Takahisa Hanada. (2019) Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model. Epilepsy Research 154, pages 42-49.
Crossref
Crossref
Jing Gan, Dan Ma & Tao Xiong. (2019) Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials. BMJ Open 9:7, pages e029811.
Crossref
Crossref
Mohamed S. Zulfarina, Syed-Badrul Syarifah-Noratiqah, Shuid A. Nazrun, Razinah Sharif & Isa Naina-Mohamed. (2019) Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient. Clinical Psychopharmacology and Neuroscience 17:2, pages 145-154.
Crossref
Crossref
Aleksandra Narczyk, Michał Mrozowicz & Sebastian Stecko. (2019) Total synthesis of levetiracetam. Organic & Biomolecular Chemistry 17:10, pages 2770-2775.
Crossref
Crossref
Mirosław Zagaja, Agnieszka Haratym-Maj, Aleksandra Szewczyk, Radoslaw Rola, Maciej Maj, Jarogniew J. Łuszczki & Marta Andres-Mach. (2019) Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain. Neuroscience Letters 696, pages 79-86.
Crossref
Crossref
Bernd J. Vorderwülbecke, Gregor Lichtner, Falk von Dincklage & Martin Holtkamp. (2018) Acute antiepileptic drug use in intensive care units. Journal of Neurology 265:12, pages 2841-2850.
Crossref
Crossref
James R. HoweVIVI, Mark F. Bear, Peyman Golshani, Eric Klann, Stuart A. Lipton, Lennart Mucke, Mustafa Sahin & Alcino J. Silva. (2018) The mouse as a model for neuropsychiatric drug development. Current Biology 28:17, pages R909-R914.
Crossref
Crossref
Tae-Won Yang, Jangsup Moon, Tae-Joon Kim, Jin-Sun Jun, Jung-Ah Lim, Soon-Tae Lee, Keun-Hwa Jung, Kyung-Il Park, Ki-Young Jung, Kon Chu & Sang Kun Lee. (2018) HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events. PLOS ONE 13:7, pages e0200812.
Crossref
Crossref
Claudio Liguori, Francesca Izzi, Natalia Manfredi, Alessio D'Elia, Luisa Mari, Nicola Biagio Mercuri & Placidi Fabio. (2018) Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study. Epilepsy & Behavior 80, pages 173-176.
Crossref
Crossref
Trond Myhrer, Espen Mariussen & Pål Aas. (2018) Development of neuropathology following soman poisoning and medical countermeasures. NeuroToxicology 65, pages 144-165.
Crossref
Crossref
Hussein Algahtani, Siham Marghalani, Mohamed Satti & Bader Shirah. (2017) Levetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect. Journal of Epilepsy Research 7:2, pages 106-108.
Crossref
Crossref
Daniele Marcotulli, Giorgia Fattorini, Luca Bragina, Jessica Perugini & Fiorenzo Conti. (2017) Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Sara M.T. Machado, Ricardo A.E. Castro, Teresa M.R. Maria, João Canotilho & M. Ermelinda S. Eusébio. (2017) Levetiracetam + nonsteroidal anti-inflammatory drug binary systems: A contribution to the development of new solid dosage forms. International Journal of Pharmaceutics 533:1, pages 1-13.
Crossref
Crossref
Jason Tan, Vanessa Paquette, Marc Levine & Mary H. H. Ensom. (2017) Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy. Clinical Pharmacokinetics 56:11, pages 1267-1285.
Crossref
Crossref
Şükrü Beydemir & Yeliz Demir. (2017) Antiepileptic drugs: Impacts on human serum paraoxonase-1. Journal of Biochemical and Molecular Toxicology 31:6, pages e21889.
Crossref
Crossref
Dominique Flügel. (2017) Status epilepticus bei Erwachsenen. Praxis 106:3, pages 143-150.
Crossref
Crossref
Amy Z. Crepeau & Joseph I. Sirven. (2017) Management of Adult Onset Seizures. Mayo Clinic Proceedings 92:2, pages 306-318.
Crossref
Crossref
Shengnian Zhou & Xinshi Wang. 2017. Refractory Status Epilepticus. Refractory Status Epilepticus
291
324
.
Christa B. Swisher & Aatif M. Husain. 2017. Seizures in Critical Care. Seizures in Critical Care
103
119
.
Lubos Remen, Olivier Bezençon, Lloyd Simons, Rick Gaston, Dennis Downing, John Gatfield, Catherine Roch, Melanie Kessler, Johannes Mosbacher, Thomas Pfeifer, Corinna Grisostomi, Markus Rey, Eric A. Ertel & Richard Moon. (2016) Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers. Journal of Medicinal Chemistry 59:18, pages 8398-8411.
Crossref
Crossref
Yu-Xing Ge, Xiang-Zhu Tian, Ying-Ying Lin & Xue-Yuan Liu. (2016) Chronic treatment with levetiracetam reverses deficits in hippocampal LTP in vivo in experimental temporal lobe epilepsy rats. Neuroscience Letters 628, pages 194-200.
Crossref
Crossref
Chryssa Pourzitaki, Georgia Tsaousi, Eirini Apostolidou, Konstantinos Karakoulas, Dimitrios Kouvelas & Ekaterini Amaniti. (2016) Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis. British Journal of Clinical Pharmacology 82:1, pages 315-325.
Crossref
Crossref
Matthew A. Kirkman, Simon Lambden & Martin Smith. (2016) Challenges in the Anesthetic and Intensive Care Management of Acute Ischemic Stroke. Journal of Neurosurgical Anesthesiology 28:3, pages 214-232.
Crossref
Crossref
Agnieszka Gunia-Krzyżak, Ewa Żesławska, Wojciech Nitek, Justyna Popiół & Henryk Marona. (2016)
Anticonvulsant Activity of Enantiomeric
N-trans
-Cinnamoyl Derivatives of 2-Aminopropan-1-ols and 2-Aminobutan-1-ols
. Chirality 28:6, pages 482-488.
Crossref
Crossref
Douglas Smith, Emily McGinnis, Diana Walleigh & Nicholas Abend. (2016) Management of Status Epilepticus in Children. Journal of Clinical Medicine 5:4, pages 47.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
155
177
.
Sarah LapointeMarie FlorescuDang K. NguyenChanez DjeffalKarl Bélanger. (2015) Prophylactic anticonvulsants for gliomas: a seven-year retrospective
analysis. Neuro-Oncology Practice 2:4, pages 192-198.
Crossref
Crossref
Murat Mert Atmaca, Elif Kocasoy Orhan, Nerses Bebek & Candan Gurses. (2015) Intravenous levetiracetam treatment in status epilepticus: A prospective study. Epilepsy Research 114, pages 13-22.
Crossref
Crossref
N. Lang, W. Esser, S. Evers, C. Kellinghaus, A. Nguento, U. Schlegel, B. Gaida, J. Gburek-Augustat, D.M. Altenmüller, L. Burghaus, F. Hoffmann, B. Fiedler, T. Bast, T. Rehfeld, S. Happe, R.J. Seitz, R. Boor & U. Stephani. (2015) Intravenous levetiracetam in clinical practice – Results from an independent registry. Seizure 29, pages 109-113.
Crossref
Crossref
Chaiyos Khongkhatithum, Lunliya Thampratankul, Natrujee Wiwattanadittakul & Anannit Visudtibhan. (2015) Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures. European Journal of Paediatric Neurology 19:4, pages 429-434.
Crossref
Crossref
Sudheer Chakravarthi, Manoj Kumar Goyal, Manish Modi, Ashish Bhalla & Parampreet Singh. (2015) Levetiracetam versus phenytoin in management of status epilepticus. Journal of Clinical Neuroscience 22:6, pages 959-963.
Crossref
Crossref
José Correa-Basurto, Roberto I. Cuevas-Hernández, Bryan V. Phillips-Farfán, Marlet MartÃnez-Archundia, Antonio Romo-Mancillas, Gema L. RamÃrez-Salinas, Óscar A. Pérez-González, José Trujillo-Ferrara & Julieta G. Mendoza-Torreblanca. (2015) Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations. Frontiers in Cellular Neuroscience 9.
Crossref
Crossref
Sheri Cotterman-Hart. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
171
193
.
Tian-fang Zeng, Yao-hua Li, Dong-mei An, Lei Chen, Ding Lei, Bei Zhang, Jin-mei Li & Dong Zhou. (2014) Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: A prospective observational study. Epilepsy Research 108:10, pages 1904-1911.
Crossref
Crossref
Vincenza Bianchi, Carlo Arfini & Matteo Vidali. (2014) Therapeutic Drug Monitoring of Levetiracetam. Therapeutic Drug Monitoring 36:5, pages 681-685.
Crossref
Crossref
Rodney Schnellbacher, Hugues Beaufrère, Dr Med Vet, Robert D. Arnold, Thomas N. TullyJrJr, Joerg Mayer & Stephen J. Divers. (2014)
Pharmacokinetics of Levetiracetam in Healthy Hispaniolan Amazon Parrots (
Amazona ventralis
) After Oral Administration of a Single Dose
. Journal of Avian Medicine and Surgery 28:3, pages 193-200.
Crossref
Crossref
Trond Myhrer & Pål Aas. (2014) Choice of approaches in developing novel medical countermeasures for nerve agent poisoning. NeuroToxicology 44, pages 27-38.
Crossref
Crossref
Hoo Rim Song, Young Sup Woo, Hee-Ryung Wang, Tae-Youn Jun & Won-Myong Bahk. (2014) How does antiepileptic drug induce suicidality? A case associated with levitracetam use. General Hospital Psychiatry 36:3, pages 360.e1-360.e2.
Crossref
Crossref
Zeid Yasiry & Simon D. Shorvon. (2014) The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure 23:3, pages 167-174.
Crossref
Crossref
Yung-Yi Lee, Jui-Hung Ko & Wen-Hung Chung. (2014) Acute generalized exanthematous pustulosis induced by levetiracetam. International Journal of Dermatology 53:1, pages e5-e6.
Crossref
Crossref
Youxin Fang, Xunyi Wu, Lan Xu, Xinghua Tang, Jianhong Wang, Guoxing Zhu & Zhen Hong. (2014) Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types. Journal of Clinical Neuroscience 21:1, pages 55-62.
Crossref
Crossref
Trond Myhrer, Siri Enger, Espen Mariussen & Pål Aas. (2013) Two medical therapies very effective shortly after high levels of soman poisoning in rats, but only one with universal utility. Toxicology 314:2-3, pages 221-228.
Crossref
Crossref
Ornella Cuomo, Vincenzo Rispoli, Antonio Leo, Giovanni Bosco Politi, Antonio Vinciguerra, Gianfranco di Renzo & Mauro Cataldi. (2013) The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion. PLoS ONE 8:11, pages e80852.
Crossref
Crossref
Huichao Zou, Samuel W. Brayer, Maxwell Hurwitz, Christian Niyonkuru, Lorraine E. Fowler & Amy K. Wagner. (2013) Neuroprotective, Neuroplastic, and Neurobehavioral Effects of Daily Treatment With Levetiracetam in Experimental Traumatic Brain Injury. Neurorehabilitation and Neural Repair 27:9, pages 878-888.
Crossref
Crossref
Lucy Chen & Jianren Mao. (2013) Update on Neuropathic Pain Treatment: Ion Channel Blockers and Gabapentinoids. Current Pain and Headache Reports 17:9.
Crossref
Crossref
Qiong Li, Dong Zhou, Qifu Li, Bo Wu & Huadong Zhou. (2013) Levetiracetam monotherapy for epilepsy. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jason W. Siefferman. (2013) Postamputation Pain in the Geriatric Population. Topics in Pain Management 28:8, pages 1-8.
Crossref
Crossref
Michele J. Beaulieu. (2013) Levetiracetam. Neonatal Network 32:4, pages 285-288.
Crossref
Crossref
Karen L. Fuller, Yi Yuen Wang, Mark J. Cook, Michael A. Murphy & Wendyl J. D’Souza. (2012) Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: A prospective randomized study. Epilepsia 54:1, pages 45-57.
Crossref
Crossref
M. Mujahid, P. Mujumdar, M. Sasikumar, S.S. Kunte & M. Muthukrishnan. (2012) An alternate synthesis of enantiomerically pure levetiracetam (Keppra®). Tetrahedron: Asymmetry 23:20-21, pages 1512-1515.
Crossref
Crossref
Gashirai K Mbizvo, Pete Dixon, Jane L Hutton & Anthony G Marson. (2012) Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jan Thöne, Gisa Ellrichmann, Pedro M. Faustmann, Ralf Gold & Aiden Haghikia. (2012) Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis. International Immunopharmacology 14:1, pages 9-12.
Crossref
Crossref
Christoph Richter, Susanne Effenberger, Tom Bschor, Udo Bonnet, Christian Haasen, Ulrich W. Preuss, Andreas Heinz, Anna Förg, Katharina Volkmar, Till Glauner & Martin Schaefer. (2012) Efficacy and Safety of Levetiracetam for the Prevention of Alcohol Relapse in Recently Detoxified Alcohol-Dependent Patients. Journal of Clinical Psychopharmacology 32:4, pages 558-562.
Crossref
Crossref
Rocco S. Calabrò, Domenico Italiano, David Militi & Placido Bramanti. (2012) Levetiracetam-associated loss of libido and anhedonia. Epilepsy & Behavior 24:2, pages 283-284.
Crossref
Crossref
Johan Zelano & Eva Kumlien. (2012) Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: A systematic review. Seizure 21:4, pages 233-236.
Crossref
Crossref
Patrycja Kwiecińska, Erik Taubøll & Ewa Ł. Gregoraszczuk. (2012) Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line. Pharmacological Reports 64:1, pages 157-165.
Crossref
Crossref
T. Bachmann, K. H. Bertheussen, S. Svalheim, M. Rauchenzauner, G. Luef, L. Gjerstad & E. Taubøll. (2011) Haematological side effects of antiepileptic drug treatment in patients with epilepsy. Acta Neurologica Scandinavica 124, pages 23-27.
Crossref
Crossref
Edmunds Z Reineks, Susan E Lawson, Katherine E Lembright & Sihe Wang. (2011) Performance Characteristics of a New Levetiracetam Immunoassay and Method Comparison With a High-Performance Liquid Chromatography Method. Therapeutic Drug Monitoring 33:1, pages 124-127.
Crossref
Crossref
Alana M Flexman, Julie L Ng & Adrian W Gelb. (2010) Acute and chronic pain following craniotomy. Current Opinion in Anaesthesiology 23:5, pages 551-557.
Crossref
Crossref